Stock listing
891725 Stock Price, News, Filings & Events — Towa Pharmaceutical Co., Ltd.
Selected listing: 891725 · LSX · EUR · DE
This page tracks Towa Pharmaceutical Co., Ltd.'s 891725:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 891725:LSX. 891725:LSX is the stock-level entry point for investors researching Towa Pharmaceutical Co., Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 891725:LSX
- Asset type
- Stock
- Market cap
- $1.13B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LSX
- Currency
- EUR
Towa Pharmaceutical Co., Ltd. 891725:LSX stock context
This page tracks Towa Pharmaceutical Co., Ltd.'s 891725:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 891725:LSX. 891725:LSX is the stock-level entry point for investors researching Towa Pharmaceutical Co., Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Towa Pharmaceutical Co., Ltd.
Towa Pharmaceutical : FY2026(1st quarter) Briefing Script and Q&A Summary of financial results meeting(319K／15P)
September 1, 2026
Consolidated Financial Results for the Three Months Ended June 30, 2026 (Based on Japanese GAAP)
August 6, 2026
Notice of Completion of Payment for the Issuance of 1st Series Class A Preferred Shares through Third-Party Allotment
July 31, 2026
Notice of Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation
July 10, 2026
Notice of Acquisition of Shares of Tanabe Pharma Factory Co., Ltd. and Transfer of Manufacturing and Marketing Approvals
July 3, 2026
Research Towa Pharmaceutical Co., Ltd.
Towa Pharmaceutical Co., Ltd. investor report
Review AI stock analysis and investor report context for 891725:LSX.
Towa Pharmaceutical Co., Ltd. company profile
View the public company page for Towa Pharmaceutical Co., Ltd. on 6ix.
Towa Pharmaceutical Co., Ltd. news
Read company news and market updates connected to Towa Pharmaceutical Co., Ltd..
Towa Pharmaceutical Co., Ltd. investor events
Find investor webinars, events, and replay context for Towa Pharmaceutical Co., Ltd..
Alternate listings
4553:TSE
JP · JPY
Alternate listing for Towa Pharmaceutical Co., Ltd.; the primary context on this page is 891725:LSX.
891725:LS
DE · EUR
Alternate listing for Towa Pharmaceutical Co., Ltd.; the primary context on this page is 891725:LSX.
6QC:GETTEX
DE · EUR
Alternate listing for Towa Pharmaceutical Co., Ltd.; the primary context on this page is 891725:LSX.
TWAPF:OTC
US · USD
Alternate listing for Towa Pharmaceutical Co., Ltd.; the primary context on this page is 891725:LSX.
6QC:FWB
DE · EUR
Alternate listing for Towa Pharmaceutical Co., Ltd.; the primary context on this page is 891725:LSX.
6QC:DUS
DE · EUR
Alternate listing for Towa Pharmaceutical Co., Ltd.; the primary context on this page is 891725:LSX.